recall
saveAurobindo Pharma USA Inc recall (Cls II)
December 11, 2024updated 5mo ago
community read0 votes
Cinacalcet Tablets, 90 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-833-30), b) 500-count HDPE bottle (NDC 65862-833-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India. 90 mg - 30 Tablets - NDC 65862-833-30 90 mg - 500 Tablets - NDC 65862-833-05 — Reason: cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit — Status: Ongoing
view source ↗Data sources
last refreshed 12m ago
Found something off?
same company · ±60 days · 4
🐶 often sniffed alongside
top 8- tagApproval118 co-mentions · 59 sources
- companyAurobindo Pharma Ltd81 co-mentions · 69 sources
- tagSmall Molecule59 co-mentions · 59 sources
- drugBUPROPION HYDROCHLORIDE26 co-mentions · 26 sources
- drugbupropion hydrochloride MR26 co-mentions · 26 sources
- drugbupropion hydrochloride ER26 co-mentions · 26 sources
- drugbupropion26 co-mentions · 26 sources
- drugAUVELITY26 co-mentions · 26 sources
comments(0)
5-min edit window · permanent after that